Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa
Clinical trial NCT01796197 · COMPLETED
Trial details
- NCT number
- NCT01796197
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2018-06-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.